Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

ASCO: Oxaliplatin does not improve outcomes for rectal cancer

Dr. Carlo Aschele - E.O. Ospedali Galliera, Italy
ASCO: Oxaliplatin does not improve outcomes for rectal cancer ( Dr. Carlo Aschele - E.O. Ospedali Galliera, Italy )
18 Jun 2009

ASCO: Bevacizumab and standard adjuvant chemotherapy: no improvement in disease-free survival for early-stage colon cancer

Dr Norman Wolmark - Chairman Dept of Human Oncology, Allegheny General Hospital, US
ASCO: Bevacizumab and standard adjuvant chemotherapy: no improvement in disease-free survival for early-stage colon cancer ( Dr Norman Wolmark - Chairman Dept of Human Oncology, Allegheny General Hospital, US )
17 Jun 2009

AACR 2009: Common genetic variations and predisposition to cancer

Prof Bruce Ponder - Cancer Research UK, Cambridge Institute
AACR 2009: Common genetic variations and predisposition to cancer ( Prof Bruce Ponder - Cancer Research UK, Cambridge Institute )
14 May 2009

AACR 2009: Anti-angiogenics to tackle brain and prostate tumours

Prof Gabriele Bergers - University of California, San Francisco
AACR 2009: Anti-angiogenics to tackle brain and prostate tumours ( Prof Gabriele Bergers - University of California, San Francisco )
14 May 2009

AACR 2009: 100 years of AACR

Dr Margaret Foti - CEO of the American Association for Cancer Research
AACR 2009: 100 years of AACR ( Dr Margaret Foti - CEO of the American Association for Cancer Research )
14 May 2009

AACR 2009: Determinants of screening colonoscopy among african-american older adults

Prof Jean Ford - Dept of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, USA
AACR 2009: Determinants of screening colonoscopy among african-american older adults ( Prof Jean Ford - Dept of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, USA )
7 May 2009

AACR 2009: Genetic influences in response to EGFR for metastatic colorectal cancer

Frederica Di Nicolantonio - Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment, University of Turin Medical School, Italy
AACR 2009: Genetic influences in response to EGFR for metastatic colorectal cancer ( Frederica Di Nicolantonio - Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment, University of Turin Medical School, Italy )
1 May 2009

AACR 2009: Combined Inhibition of Histone Deacetylase and mTOR: A Novel Therapeutic Approach for Pancreatic Cancer

Dr Mamta Gupta - Mayo Clinic Cancer Center, USA
AACR 2009: Combined Inhibition of Histone Deacetylase and mTOR: A Novel Therapeutic Approach for Pancreatic Cancer ( Dr Mamta Gupta - Mayo Clinic Cancer Center, USA )
30 Apr 2009

Bacteria as agents to initiate potent anti-tumour activity

Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of Oncology, Milan
Bacteria as agents to initiate potent anti-tumour activity ( Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of Oncology, Milan )
31 Mar 2009

ECCO 15 - ESMO 34 Executive Scientific Programme Committee

ECCO-ESMO Roundtable discussion - Full Version
ECCO 15 - ESMO 34 Executive Scientific Programme Committee ( ECCO-ESMO Roundtable discussion - Full Version )
16 Feb 2009

University Hospital Gasthuisberg

Prof. Eric Van Cutsem
University Hospital Gasthuisberg ( Prof. Eric Van Cutsem )
4 Dec 2008

Flinders University, Australia

Dr. Christos Karapetis
Flinders University, Australia ( Dr. Christos Karapetis )
4 Dec 2008